title: Multiple myeloma and immunomodulation: regulating the regulatory cells.
authors.affiliation: Cancer Basic Science, Mayo Clinic, Jacksonville, FL 32224, USA.
authors.forename: Chitta S
authors.initials: CS
authors.lastname: Kasyapa
authors.forename: Taimur
authors.initials: T
authors.lastname: Sher
authors.forename: Asher A
authors.initials: AA
authors.lastname: Chanan-Khan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D000242:Cyclic AMP / Q000276:immunology / Q000378:metabolism; D003907:Dexamethasone / Q000008:administration & dosage; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage; D056747:Immunomodulation / Q000187:drug effects / Q000276:immunology*; D000077269:Lenalidomide; D008297:Male; D018448:Models, Immunological; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology*; D015398:Signal Transduction / Q000187:drug effects / Q000276:immunology; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000187:drug effects / Q000276:immunology* / Q000378:metabolism; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives
chemical_list: D005938:Glucocorticoids; D007155:Immunologic Factors; D013792:Thalidomide; D003907:Dexamethasone; D000242:Cyclic AMP; D000077269:Lenalidomide